Equities

Lincoln Pharmaceuticals Ltd

LINCOLN:NSI

Lincoln Pharmaceuticals Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)728.90
  • Today's Change2.85 / 0.39%
  • Shares traded37.02k
  • 1 Year change+45.05%
  • Beta0.8460
Data delayed at least 15 minutes, as of Sep 20 2024 11:28 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue5,8055,1034,721
OPERATING EXPENSES
Cost of revenue total2,9152,5332,281
Selling, general and admin. expenses, total1,8901,6721,482
Depreciation/amortization1069281
Unusual expense(income)------
Other operating expenses, total1.710.170.28
Total operating expense4,9124,2983,844
Operating income893805877
Other, net(5.19)(3.92)(5.31)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes1,2221,005959
Provision for income taxes289276266
Net income after taxes933729694
Minority interest------
Net income before extra. Items933729694
Total extraordinary items------
Net income933729694
Inc.avail. to common excl. extra. Items933729694
Inc.avail. to common incl. extra. Items933729694
EPS RECONCILIATION
Basic/primary weighted average shares202020
Basic/primary eps excl. extra items473635
Basic/primary eps incl. extra items473635
Dilution adjustment------
Diluted weighted average shares202020
Diluted eps excl. extra items473635
Diluted eps incl. extra items473635
COMMON STOCK DIVIDENDS
DPS - common stock primary issue1.801.501.50
Gross dividend - common stock303030
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental9.46169.20
SUPPLEMENTAL INCOME
Depreciation, supplemental1059180
Total special items0.222.561.31
NORMALISED INCOME
Normalized income before taxes1,2231,007961
Effect of special items on income taxes0.050.700.36
Income tax excluding impact of special items289277266
Normalized income after tax933731694
Normalized income avail. to common933731694
Basic normalized EPS473635
Diluted normalized EPS473635
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.